C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.670
+0.080 (3.09%)
At close: Dec 5, 2025, 4:00 PM EST
2.642
-0.028 (-1.05%)
After-hours: Dec 5, 2025, 7:59 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $258.76 million as of December 5, 2025. Its market cap has decreased by -11.67% in one year.
Market Cap
258.76M
Enterprise Value
120.47M
1-Year Change
-11.67%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $258.76M, a decrease of -66.51%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 258.76M | 1.83% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |